EE200100196A - a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks - Google Patents

a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks

Info

Publication number
EE200100196A
EE200100196A EEP200100196A EEP200100196A EE200100196A EE 200100196 A EE200100196 A EE 200100196A EE P200100196 A EEP200100196 A EE P200100196A EE P200100196 A EEP200100196 A EE P200100196A EE 200100196 A EE200100196 A EE 200100196A
Authority
EE
Estonia
Prior art keywords
analogs
pharmaceutical compositions
oral administration
based pharmaceutical
cyclodextrin based
Prior art date
Application number
EEP200100196A
Other languages
English (en)
Inventor
Delansorne R�mi
Bonnet Paule
Paris Jacques
Original Assignee
Laboratoire Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex filed Critical Laboratoire Theramex
Publication of EE200100196A publication Critical patent/EE200100196A/et
Publication of EE04872B1 publication Critical patent/EE04872B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
EEP200100196A 1998-09-30 1999-09-23 a-tsklodekstriini v?i selle derivaadi kasutamineLH-RH peptiidanaloogi sisaldavate farmatseutiliste kompositsioonide valmistamiseks ja a-tsklodekstriinil p?hinev farmatseutiline kompositsioon LH-RHpeptiidanaloogide peroraalseks manustamiseks EE04872B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98402403A EP0998940A1 (en) 1998-09-30 1998-09-30 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
PCT/EP1999/007389 WO2000018423A1 (en) 1998-09-30 1999-09-23 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues

Publications (2)

Publication Number Publication Date
EE200100196A true EE200100196A (et) 2002-06-17
EE04872B1 EE04872B1 (et) 2007-08-15

Family

ID=8235503

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100196A EE04872B1 (et) 1998-09-30 1999-09-23 a-tsklodekstriini v?i selle derivaadi kasutamineLH-RH peptiidanaloogi sisaldavate farmatseutiliste kompositsioonide valmistamiseks ja a-tsklodekstriinil p?hinev farmatseutiline kompositsioon LH-RHpeptiidanaloogide peroraalseks manustamiseks

Country Status (28)

Country Link
EP (2) EP0998940A1 (et)
JP (1) JP4485060B2 (et)
KR (1) KR100652457B1 (et)
CN (1) CN1200727C (et)
AR (1) AR023056A1 (et)
AT (1) ATE218358T1 (et)
AU (1) AU756233B2 (et)
BR (1) BR9914125A (et)
CA (1) CA2344470C (et)
CZ (1) CZ302343B6 (et)
DE (1) DE69901721T2 (et)
DK (1) DK1117420T3 (et)
EE (1) EE04872B1 (et)
ES (1) ES2178478T3 (et)
HK (1) HK1042047B (et)
HU (1) HUP0103649A3 (et)
ID (1) ID28650A (et)
IL (2) IL142112A0 (et)
MX (1) MXPA01003340A (et)
NO (1) NO330234B1 (et)
NZ (1) NZ510446A (et)
PL (1) PL200693B1 (et)
PT (1) PT1117420E (et)
RU (1) RU2214270C2 (et)
SI (1) SI1117420T1 (et)
TR (1) TR200100887T2 (et)
WO (1) WO2000018423A1 (et)
ZA (1) ZA200102452B (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
SE0104462D0 (sv) * 2001-12-29 2001-12-29 Carlbiotech Ltd As Peptide purifcation (Peptidrening)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
US4659969A (en) * 1984-08-09 1987-04-21 Synektron Corporation Variable reluctance actuator having position sensing and control
PT88490B (pt) * 1987-09-14 1992-11-30 Novo Nordisk As Processo para a preparacao de composicoes farmaceuticas para libertacao nao-enterica trans-mucosa contendo monossacaridos ou oligossacaridos
SI9300470A (en) * 1993-09-10 1995-04-30 Lek Tovarna Farmacevtskih Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
DE69730093T2 (de) * 1996-10-31 2006-07-20 Takeda Pharmaceutical Co. Ltd. Zubereitung mit verzögerter Freisetzung
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR20010075255A (ko) 2001-08-09
EP1117420B1 (en) 2002-06-05
RU2214270C2 (ru) 2003-10-20
TR200100887T2 (tr) 2001-10-22
NZ510446A (en) 2003-01-31
WO2000018423A1 (en) 2000-04-06
AR023056A1 (es) 2002-09-04
ES2178478T3 (es) 2002-12-16
EP0998940A1 (en) 2000-05-10
PL200693B1 (pl) 2009-01-30
ATE218358T1 (de) 2002-06-15
MXPA01003340A (es) 2004-04-21
DE69901721T2 (de) 2003-01-09
ZA200102452B (en) 2002-03-26
NO330234B1 (no) 2011-03-07
HUP0103649A3 (en) 2002-05-28
AU756233B2 (en) 2003-01-09
CN1200727C (zh) 2005-05-11
NO20011576L (no) 2001-03-28
CN1324241A (zh) 2001-11-28
ID28650A (id) 2001-06-21
JP2002525336A (ja) 2002-08-13
EP1117420A1 (en) 2001-07-25
PL346939A1 (en) 2002-03-11
BR9914125A (pt) 2001-06-19
EE04872B1 (et) 2007-08-15
IL142112A (en) 2006-10-31
DK1117420T3 (da) 2002-09-16
KR100652457B1 (ko) 2006-11-30
SI1117420T1 (en) 2002-12-31
CZ20011173A3 (cs) 2001-09-12
PT1117420E (pt) 2002-10-31
AU6199999A (en) 2000-04-17
JP4485060B2 (ja) 2010-06-16
CA2344470A1 (en) 2000-04-06
HK1042047B (zh) 2005-12-16
IL142112A0 (en) 2002-03-10
DE69901721D1 (de) 2002-07-11
CA2344470C (en) 2009-01-06
HUP0103649A2 (hu) 2002-02-28
CZ302343B6 (cs) 2011-03-23
NO20011576D0 (no) 2001-03-28

Similar Documents

Publication Publication Date Title
PL342988A1 (en) Novel galenic formulations of meloxicam for oral administration
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
EE04578B1 (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nendesolvaatide suu kaudu manustamiseks
DK0876131T3 (da) Sammensætninger til lægemiddelindgivelse til forbedret stabilitet af androgener
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
EE200200075A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kompositsioonid
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
NO991613D0 (no) Farmas°ytiske mikrosfµrer av valpronsyre for oral administrering
NO993927L (no) Farmasöytiske blandinger i törr form for oral administrasjon av en syklisk kvaternær ammoniumforbindelse
EE200100196A (et) a-tsüklodekstriinil põhinevad farmatseutilised kompositsioonid LH-RH analoogide peroraalseks manustamiseks
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
NO20032581D0 (no) Farmasöytisk formulering av gepiron for oral administrering
ES2170168T3 (es) Composiciones recubiertas entericamente de derivados de 1,5-benzodiacepina con actividad antagonista o agonista de cck.
ITMI20010009A0 (it) Composizioni farmaceutica contenente brivudina per la singola somministrazione giornaliera
DK1165081T3 (da) Fremgangsmåde til fremstilling af tolperisonholdige farmaceutiske præparater til oral indgivelse
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
KR970701559A (ko) 펩타이드의 경구 투여를 위한 안정화된 조성물(stabilized composition for oral administration of peptides)
ITMI920214A1 (it) Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina
ITPD920141A0 (it) Formulazione farmaceutiche per la somministraziane orale di calcitoni-na
ITMI992202A0 (it) Composizioni farmaceutiche contenenti farmaci antiinfiammatori
SI0927031T1 (en) Pharmaceutical preparation containing nimesulide for oral administration
EP1133996A4 (en) DRUG COMPOSITIONS WITH PERIODIC ADMINISTRATION

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110923